Page last updated: 2024-11-05

triamterene and Gynecomastia

triamterene has been researched along with Gynecomastia in 2 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Gynecomastia: Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holzgreve, H1
Yamamoto, S1

Other Studies

2 other studies available for triamterene and Gynecomastia

ArticleYear
[Therapy of cardiac insufficiency with diuretics].
    Fortschritte der Medizin, 1982, Aug-26, Volume: 100, Issue:31-32

    Topics: Amiloride; Benzothiadiazines; Blood Glucose; Diuretics; Drug Administration Schedule; Female; Furose

1982
Disappearance of spironolactone-induced gynecomastia with triamteren.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:6

    Topics: Diuretics; Gynecomastia; Humans; Male; Middle Aged; Remission Induction; Spironolactone; Triamterene

2001